Stimson KM and Vertino PM |
Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture. |
2002 |
J. Biol. Chem. |
pmid:11733524
|
Wilson MA et al. |
The histone deacetylase inhibitor trichostatin A blocks progesterone receptor-mediated transactivation of the mouse mammary tumor virus promoter in vivo. |
2002 |
J. Biol. Chem. |
pmid:11821430
|
Deroanne CF et al. |
Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. |
2002 |
Oncogene |
pmid:11821955
|
Zhang W and Kone BC |
NF-kappaB inhibits transcription of the H(+)-K(+)-ATPase alpha(2)-subunit gene: role of histone deacetylases. |
2002 |
Am. J. Physiol. Renal Physiol. |
pmid:12372765
|
Handumrongkul C et al. |
Distinct sets of cellular genes control the expression of transfected, nuclear-localized genes. |
2002 |
Mol. Ther. |
pmid:11829526
|
Ailenberg M and Silverman M |
Trichostatin A-histone deacetylase inhibitor with clinical therapeutic potential-is also a selective and potent inhibitor of gelatinase A expression. |
2002 |
Biochem. Biophys. Res. Commun. |
pmid:12379227
|
Yamashita K et al. |
Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. |
2002 |
Cancer Cell |
pmid:12498717
|
Fahrner JA et al. |
Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. |
2002 |
Cancer Res. |
pmid:12499261
|
Kikuchi T et al. |
Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer. |
2002 |
Int. J. Cancer |
pmid:11774276
|
Rombouts K et al. |
Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in skin fibroblasts. |
2002 |
Exp. Cell Res. |
pmid:12169274
|
Waterborg JH and Kapros T |
Kinetic analysis of histone acetylation turnover and Trichostatin A induced hyper- and hypoacetylation in alfalfa. |
2002 |
Biochem. Cell Biol. |
pmid:12123281
|
Nair RR et al. |
Enhancement of transgene expression by combining glucocorticoids and anti-mitotic agents during transient transfection using DNA-cationic liposomes. |
2002 |
Mol. Ther. |
pmid:11945073
|
Qiu P and Li L |
Histone acetylation and recruitment of serum responsive factor and CREB-binding protein onto SM22 promoter during SM22 gene expression. |
2002 |
Circ. Res. |
pmid:11988486
|
Mai A et al. |
Binding mode analysis of 3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide: a new synthetic histone deacetylase inhibitor inducing histone hyperacetylation, growth inhibition, and terminal cell differentiation. |
2002 |
J. Med. Chem. |
pmid:11960489
|
Merezak C et al. |
Inhibition of histone deacetylases induces bovine leukemia virus expression in vitro and in vivo. |
2002 |
J. Virol. |
pmid:11967319
|
Gálfi P et al. |
Apoptosis sensitivity is not correlated with sensitivity to proliferation inhibition by the histone deacetylase inhibitors butyrate and TSA. |
2002 |
Cancer Lett. |
pmid:12406559
|
Travers H et al. |
Human CD34+ hematopoietic progenitor cells hyperacetylate core histones in response to sodium butyrate, but not trichostatin A. |
2002 |
Exp. Cell Res. |
pmid:12413881
|
Wilson AJ et al. |
Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. |
2002 |
Cancer Res. |
pmid:12414619
|
Choy JS and Kron SJ |
NuA4 subunit Yng2 function in intra-S-phase DNA damage response. |
2002 |
Mol. Cell. Biol. |
pmid:12417725
|
Ghoshal K et al. |
Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure. |
2002 |
Mol. Cell. Biol. |
pmid:12417732
|